about company
OUR COMMITMENT
OUR STRATEGY
OUR HISTORY
OUR PRODUCTS
DIABETES
ONCOLOGY
CONSUMER HEALTHCARE
GENERICS
ANIMAL HEALTH
RESEARCH
Contacts
Manufactured by: Q Lab, Inc. 1604 Glen Shee Rd.
Prince George, BC, Canada www.qlab.cc
Key facts
QLab, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease.
OUR COMMITMENT
We work to protect the health of the earth’s 7 billion inhabitants, improve their quality of life and respond to their potential needs. We are creating new approaches to our activities and work sectors, and are mobilized for our priority goal of bringing medicines and vaccines to patients.
Innovating
To make tomorrow’s therapeutic solutions real, we seek to innovate with our partners, who, like us, aim for excellence and efficiency.
Dedicating
In all of our activities, we commit our energy and expertise to patients and address the veritable needs and realities of each market. Our passion is a cornerstone of what we do, because health matters.
Standing together  
We are a company committed to the cause of health. Acting with ethics and responsibility is weaved into the very fabric of who we are.
Helping, be it during emergencies or in daily life, means going beyond our obligations to protect and serve the greatest possible number of people.
OUR STRATEGY
A diversified healthcare partner focused on patients needs
At the heart of everything we do are people. Through our vaccines and medicines, we help prevent and where needed, treat those in need. As economies and societies evolve, we need healthy populations to meet the future challenges we will face. Healthcare needs have changed and will continue to do so and as an industry we have to adapt to meet these needs.   
To have a real impact, we have to build a sustainable  business to invest in delivering innovative solutions. At the same time we need  to improve access to medicines and improved healthcare. In order to move along  in this ambition, we continue to push forward with our key strategic  priorities: 
Increasing innovation in Research & Development 
R&D has always been and will continue to be the cornerstone of our company. The advancements in science mean that more targeted, more effective treatments are in reach and we are ready to take on this challenge. We have built a revitalized R&D organization focused on meeting unmet needs of patients and delivering truly innovative solutions.
Seizing external growth  opportunities
The changing face of the industry, healthcare needs and  scientific discovery has all led to the realization that we need to diversify  and look outside at partnerships and acquisitions to grow the business. We have  been successful in searching out the best science, the best companies to  acquire. We have strongly reinforced our business in partic